Memory loss / memory impaired / memory alteration

• (2021): Vicente-Valor J+, Biomed Pharmacother Dec, Online ahead of print (2 cases)

Neuropsychiatric / neuropsychological adverse effect

• (2020): di Mauro G+, Drug Saf Dec, Online ahead of print [REVIEW]

Hypertransaminasemia (hepatic transaminitis) / elevated transaminases

• (2021): Vicente-Valor J+, Biomed Pharmacother Dec, Online ahead of print2%

Application-site reactions

• (2022): Feng Z+, Front Pharmacol Nov (e-Collection)

Injection-site reaction

• (2021): Vicente-Valor J+, Biomed Pharmacother Dec, Online ahead of print11%

Arthralgia

• (2021): Vicente-Valor J+, Biomed Pharmacother Dec, Online ahead of print26%

Asthenia / fatigue

• (2021): Vicente-Valor J+, Biomed Pharmacother Dec, Online ahead of print5%

Musculoskeletal adverse effects

• (2022): Feng Z+, Front Pharmacol Nov (e-Collection)

Myalgia/Myositis/Myopathy/Myotoxicity

• (2021): Vicente-Valor J+, Biomed Pharmacother Dec, Online ahead of print26%

Respiratory tract symptoms

• (2021): Vicente-Valor J+, Biomed Pharmacother Dec, Online ahead of print4%

Adverse effects / adverse reactions

• Negative findings
• (2026): Olmastroni E+, Eur J Prev Cardiol May, Online ahead of print [REVIEW] ("reassuring short-term safety profile")